In addition, AMPK can also regulate pathways such as mTOR, autophagy, and Nrf2, alleviating oxidative damage and metabolic imbalance related to NAFLD. The gene discussed is PRKAA1; the disease is metabolic dysfunction-associated steatotic liver disease.